Nicholas W. Bateman, Ph.D.
Affiliations: | 2010 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Pharmacology, Oncology, BiochemistryGoogle:
"Nicholas Bateman"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Thomas P. Conrads | grad student | 2010 | University of Pittsburgh | |
| (A proteomic analysis of neoplastic progression in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Randall J, Hunt AL, Nutcharoen A, et al. (2024) Quantitative proteomic analysis of HER2 protein expression in PDAC tumors. Clinical Proteomics. 21: 24 |
| Bateman NW, Abulez T, Soltis AR, et al. (2024) Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities. Npj Precision Oncology. 8: 68 |
| Sitler CA, Tian C, Hamilton CA, et al. (2024) Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer-Accredited Facilities in the United States. Cancers. 16 |
| Teng PN, Schaaf JP, Abulez T, et al. (2024) ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data. Iscience. 27: 109198 |
| Kucera CW, Chappell NP, Tian C, et al. (2024) Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecologic Oncology. 184: 224-235 |
| Winkler SS, Tian C, Casablanca Y, et al. (2024) Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes. Gynecologic Oncology. 184: 31-42 |
| Hunt AL, Bateman NW, Barakat W, et al. (2024) Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. Clinical Proteomics. 21: 4 |
| Buddenkotte T, Rundo L, Woitek R, et al. (2023) Deep learning-based segmentation of multisite disease in ovarian cancer. European Radiology Experimental. 7: 77 |
| McGee JP, Su P, Durbin KR, et al. (2023) Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue. Nature Communications. 14: 7946 |
| Corvigno S, Badal S, Spradlin ML, et al. (2023) In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. Npj Precision Oncology. 7: 115 |